Skip to main content
CG MedTech Co.,Ltd. logo

CG MedTech Co.,Ltd. — Investor Relations & Filings

Ticker · 056090 ISIN · KR7056090004 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2024-01-11 AGM Information
Country KR South Korea
Listing KO 056090

About CG MedTech Co.,Ltd.

https://cgmedt.com/

CG MedTech Co., Ltd. is a medical technology company that designs, manufactures, and distributes orthopedic medical devices and surgical implants. The company's product portfolio encompasses solutions for spine, trauma, pain management, sports medicine, and biologics. Key offerings include spinal fixation devices, bioabsorbable alloy implants, and systems for fracture treatment. CG MedTech focuses on regenerative medicine and the development of innovative technologies, such as patient-specific 3D printed implants, to enhance tissue regeneration and improve patient outcomes.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회소집결의' (Resolution for Convening a General Meeting) and includes a '정정신고' (Correction Report). It details the agenda for an upcoming Extraordinary General Meeting, specifically focusing on the appointment of directors and changes to the articles of incorporation. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and proposed resolutions.
2024-01-11 Korean
[기재정정]최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system (KIND) regarding a 'Change in Largest Shareholder' due to a stock purchase agreement. It is a 'Correction Report' (정정신고) detailing changes to payment schedules and terms of a previously announced M&A-related transaction. Since this document details the specific terms, parties, and financial structure of a change in control/ownership, it falls under the category of M&A Activity (TAR).
2024-01-11 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Inosis'. It details the agenda, including the appointment of new directors and amendments to the articles of incorporation. This type of document is a standard proxy solicitation or information statement provided to shareholders to inform them of upcoming meeting agendas and to request their participation/votes. In the provided taxonomy, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for documents detailing meeting agendas and director nominations.
2024-01-10 Korean
신주인수권행사(제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of stock warrants (신주인수권행사) by the company Innosys. It details the number of shares issued, the exercise price, and the impact on total shares outstanding. This falls under the category of capital changes resulting from the exercise of financial instruments, which is best classified as Share Issue/Capital Change.
2024-01-09 Korean
투자판단관련주요경영사항(Stent 및 관련 부자재 유통 매입계약 종료)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) titled 'Investment Judgment Related Major Management Matters'. It details the termination of a supply contract for medical stents. Since it is a specific corporate announcement regarding a material business event (contract termination) that does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2024-01-02 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Innosys) regarding the rescheduling of an Extraordinary General Meeting (EGM). It details the change in the meeting date and provides the updated schedule and agenda items. Since this is a formal notice regarding the convening of a shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI) as it relates to the formal process of calling and informing shareholders about a meeting.
2023-12-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.